PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Projected health system and economic impacts of 2025 Medicaid policy proposals

JAMA Health Forum

2025-07-16
(Press-News.org) About The Study: This analysis indicates that proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings, including negative health outcomes, economic losses, and health care system disruptions, with rural and underserved communities disproportionately affected.

Corresponding Author: To contact the corresponding author, Sanjay Y. Basu, MD, PhD, email sanjay.basu@ucsf.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2025.3187)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.3187?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=071625

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

END


ELSE PRESS RELEASES FROM THIS DATE:

New tech for imaging brain waves could advance disease research, AI

2025-07-16
When electrical activity travels across the brain, it moves like ripples on a pond. The motion of these “brain waves,” first observed in the 1920s, can now be seen more clearly than ever before thanks to instruments and techniques created by a Stanford-led team. The technology, described in the journal Cell, involves two ultra-sensitive optical instruments that can detect signals of genetically engineered proteins, known as “voltage indicators,” revealing neuronal brain wave activity in mice. While limited to research animals, the advance has already shown its potential. Using these instruments, the researchers ...

Immigrants in U.S. earn 10.6% less than native-born workers, but biggest driver is job access, not wage discrimination 

2025-07-16
AMHERST, Mass. — Immigrants in the United States earn 10.6% less than similarly educated U.S.-born workers, largely because they are concentrated in lower-paying industries, occupations and companies, according to a major new study published today in Nature, co-authored by a University of Massachusetts Amherst sociologist who studies equal opportunity in employment. The research—one of the most comprehensive global comparisons of immigrant labor market integration to date—analyzes linked employer-employee ...

New peer-reviewed study reveals severe health and economic consequences of 2025 Medicaid policy changes

2025-07-16
Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published peer-reviewed research in JAMA Health Forum examining the projected health system and economic impacts of 2025 Medicaid policy changes. The study, conducted in collaboration with researchers at the University of North Carolina at Chapel Hill, reveals that H.R. 1, the "One Big Beautiful Bill Act" recently passed by Congress, could result in devastating consequences for vulnerable populations, rural communities, and local economies nationwide. Numerous studies from multiple organizations, including the nonpartisan ...

Faster, smarter, more open: a new way to accelerate AI models

2025-07-16
Just as people from different countries speak different languages, AI models also create various internal “languages” – a unique set of tokens understood only by each model. Until recently, there was no way for models developed by different companies to communicate directly, collaborate or combine their strengths to improve performance. This week, at the International Conference on Machine Learning (ICML) in Vancouver, Canada, scientists from the Weizmann Institute of Science and Intel Labs are presenting a ...

What does it cost an animal to fight?

2025-07-16
How do animals decide when to fight and when to walk, fly, slither, or swim away? Most research on animal conflict has focused on the short-term costs of single interactions, but a pair of behavioral ecologists argue that these one-time events might paint an incomplete picture. In an opinion paper publishing July 16 in the Cell Press journal Trends in Ecology & Evolution, the researchers say that to really understand the consequences of animal conflict, we need to also consider its long-term and cumulative impact on an individual’s longevity and reproduction.  “By linking individual contests to lifetime reproductive success, we ...

Discovery could battle Alzheimer’s by boosting blood flow to brain

2025-07-16
New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow to the brain to battle Alzheimer’s and other neurodegenerative diseases. Scientists led by Ukpong B. Eyo, PhD, of UVA’s Department of Neuroscience, found that immune cells called microglia play an essential role in determining how well tiny capillaries deliver blood and essential nourishment to our brains. The scientists believe problems with these microglia could be contributing to failing brain health, and targeting them could help us prevent or reverse memory-stealing diseases caused or worsened by lack of adequate blood flow. This could include Alzheimer’s, ...

New antibody selectively targets immune cells that suppress anti-tumor responses

2025-07-16
“Taken together, our studies suggest that 2B010 represents an anti-CD25 mAb with unique properties in that it deleted Treg from an inflammatory environment (GVHD) as well as from the TME.” BUFFALO, NY – July 16, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment.” In this study, researchers from the National Institute of Allergy and Infectious Diseases, led by first author Maja ...

OHSU scientists develop tool that improves tissue cancer analysis

2025-07-16
Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is crucial for understanding diseases such as cancer. Developed by researchers at Oregon Health & Science University’s Knight Cancer Institute, the tool, dubbed OmicsTweezer, uses advanced machine learning techniques to analyze biological data at a scale large enough to estimate the composition of cell types in a sample of tissue that may be taken from a biopsy. This process allows scientists to map the cellular makeup of tumors and surrounding tissues — an area ...

The 2025 World Cultural Council’s award winner is announced

2025-07-16
The 2025 World Cultural Council’s award winner is announced The winner of the 2025 “Albert Einstein” World Award of Science is Professor Mercouri G. Kanatzidis, Charles E. and Emma H. Morrison Professor in the Department of Chemistry and the Department of Materials Science and Engineering at Northwestern University, USA. He is also a Senior Scientist at Argonne National Laboratory. Professor Kanatzidis is recognized for his groundbreaking contributions as a pioneer in shaping the field solar photovoltaic materials through his seminal work on halide perovskite semiconductors. He has made fundamental contributions for creating materials enabling ...

Stephenson Global Scholar Grants Program awards $5.3 million to drive breakthroughs in pancreatic cancer research

2025-07-16
The significant philanthropic support comes at a time of uncertainty for federal research funding The grants will support new approaches to the deadliest cancer, from novel early detection methods, using AI to identify those with higher risk, and new immunotherapy treatments LOS ANGELES, July 16, 2025 — The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country’s largest and most advanced cancer research and treatment organizations, today announced the six inaugural recipients of the prestigious Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Projected health system and economic impacts of 2025 Medicaid policy proposals
JAMA Health Forum